{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T13:15:47Z","timestamp":1794921347503,"version":"4.9.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["annemergmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.annemergmed.2025.12.004","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T04:49:11Z","timestamp":1769143751000},"page":"709-716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Emergence of Medetomidine in the Illicit Drug Supply: Implications for Emergency Care and Withdrawal Management"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8014-6530","authenticated-orcid":false,"given":"Michael J.","family":"Lynch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony F.","family":"Pizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Yealy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2025.12.004_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib2","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1002\/jcph.1860","article-title":"Inherent dangers of using non-US Food and Drug Administration-approved substances of abuse","volume":"61","author":"White","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib3","author":"Payer","year":"2020"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib4","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.15585\/mmwr.mm675152a3","article-title":"Wound botulism outbreak among persons who use black tar heroin\u2014San Diego County, California, 2017-2018","volume":"67","author":"Peak","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.15585\/mmwr.mm6721a4","article-title":"Notes from the field: outbreak of severe illness linked to the vitamin k antagonist brodifacoum and use of synthetic cannabinoids\u2014Illinois, March-April 2018","volume":"67","author":"Moritz","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib6","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1089\/fpd.2022.0013","article-title":"A multiple-serotype outbreak of Salmonella infections linked to Kratom, United States, 2017-2018","volume":"19","author":"Schwensohn","year":"2022","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00000542-199409000-00022","article-title":"Potentiation of the analgesic properties of fentanyl-like opioids with alpha 2-adrenoceptor agonists in rats","volume":"81","author":"Meert","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1747-597X-6-7","article-title":"Xylazine (veterinary sedative) use in Puerto Rico","volume":"6","author":"Torruella","year":"2011","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/injuryprev-2020-043968","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010-2019","volume":"27","author":"Johnson","year":"2021","journal-title":"Inj Prev"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112826","article-title":"Amputation trends among people who use drugs in the context of Philadelphia's increasingly xylazine adulterated drug supply","volume":"275","author":"Laurano","year":"2025","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","article-title":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature","volume":"240","author":"Ruiz-Col\u00f3n","year":"2014","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib13","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/29767342251329681","article-title":"Building multidisciplinary consensus on inpatient xylazine management through clinical protocols","volume":"46","author":"Shang","year":"2025","journal-title":"Subst Use Addctn J"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib14","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/jama.2024.15992","article-title":"Medetomidine infiltrates the US illicit opioid market","volume":"332","author":"Palamar","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib15","article-title":"Medetomidine rapidly proliferating across USA \u2014 implicated in recreational opioid drug supply & causing overdose outbreaks","author":"Krotulski","year":"2024","journal-title":"Center for Forensic Science Research and Education"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.15585\/mmwr.mm7415a1","article-title":"Overdoses involving medetomidine mixed with opioids\u2014Chicago, Illinois, May 2024","volume":"74","author":"Nham","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.15585\/mmwr.mm7415a2","article-title":"Notes from the field: suspected medetomidine withdrawal syndrome among fentanyl-exposed patients\u2014Philadelphia, Pennsylvania, September 2024-January 2025","volume":"74","author":"Huo","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.15585\/mmwr.mm7415a3","article-title":"Notes from the field: severe medetomidine withdrawal syndrome in patients using illegally manufactured opioids\u2014Pittsburgh, Pennsylvania, October 2024-March 2025","volume":"74","author":"Ostrowski","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib19","article-title":"The shifting landscape of a fentanyl adulterant: moving from xylazine to medetomidine","author":"Huo","year":"2025","journal-title":"J Addict Med"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib20","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s40262-017-0507-7","article-title":"Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine","volume":"56","author":"Weerink","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib21","first-page":"29","article-title":"Pharmacological profiles of medetomidine and its antagonist, atipamezole","volume":"85","author":"Virtanen","year":"1989","journal-title":"Acta Vet Scand Suppl"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib22","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1365-2125.2003.01944.x","article-title":"Bioavailability of dexmedetomidine after extravascular doses in healthy subjects","volume":"56","author":"Anttila","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00000542-200008000-00016","article-title":"The effects of increasing plasma concentrations of dexmedetomidine in humans","volume":"93","author":"Ebert","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib24","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/00000542-199212000-00014","article-title":"Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes","volume":"77","author":"Bloor","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib25","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00000542-200411000-00005","article-title":"Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers","volume":"101","author":"Hsu","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib26","article-title":"Perioperative dexmedetomidine for acute pain after abdominal surgery in adults","volume":"2","author":"Lundorf","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0009-9236(99)80045-9","article-title":"Pharmacokinetics of dexmedetomidine (DEX) in patients with hepatic failure (HF)","volume":"65","author":"Cunningham","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib28","article-title":"Responding to medetomidine: clinical and public health needs","volume":"44","author":"Zhu","year":"2025","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib29","series-title":"Changes in Philadelphia\u2019s drug supply and substance use-related emergency department visits","author":"Puleo","year":"2025"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1527-3458.2005.tb00047.x","article-title":"Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist","volume":"11","author":"Pertovaara","year":"2005","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib31","article-title":"Incidence of dexmedetomidine withdrawal in adult critically ill patients: a pilot study","volume":"1","author":"Bouajram","year":"2019","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcrc.2020.10.024","article-title":"Evaluation of dexmedetomidine withdrawal in critically ill adults","volume":"62","author":"Pathan","year":"2021","journal-title":"J Crit Care"},{"issue":"11","key":"10.1016\/j.annemergmed.2025.12.004_bib33","article-title":"Effect of enteral guanfacine on dexmedetomidine use in the ICU","volume":"4","author":"Fetters","year":"2022","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5492\/wjccm.v12.i1.18","article-title":"Clonidine use during dexmedetomidine weaning: a systematic review","volume":"12","author":"Rajendraprasad","year":"2023","journal-title":"World J Crit Care Med"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib35","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jama.2024.27550","article-title":"UV stabilizer BTMPS in the illicit fentanyl supply in 9 US locations","volume":"333","author":"Shover","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/ADM.0000000000001560","article-title":"Severe fentanyl withdrawal associated with medetomidine adulteration: a multicenter study from Philadelphia, PA","volume":"20","author":"London","year":"2026","journal-title":"J Addict Med"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib37","article-title":"Implementation of a clinical pathway to screen and treat medical inpatients for opioid withdrawal","volume":"3","author":"Williams","year":"2022","journal-title":"Implement Res Pract"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/JCP.0000000000001004","article-title":"Pharmacokinetics and pharmacodynamics of immediate-release versus extended-release guanfacine in adult daily smokers","volume":"39","author":"Verplaetse","year":"2019","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib41","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1524-6175.2005.04133.x","article-title":"Transdermal clonidine: therapeutic considerations","volume":"7","author":"Sica","year":"2005","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.9758\/cpn.2023.21.2.215","article-title":"Sublingual dexmedetomidine for the treatment of agitation in patients with schizophrenia and bipolar disorder","volume":"21","author":"Smith","year":"2023","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"Suppl 9","key":"10.1016\/j.annemergmed.2025.12.004_bib43","first-page":"S6","article-title":"Tizanidine: neuropharmacology and mechanism of action","volume":"44","author":"Coward","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2020.107327","article-title":"Guanfacine's mechanism of action in treating prefrontal cortical disorders: successful translation across species","volume":"176","author":"Arnsten","year":"2020","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2344\/0003-3006-62.1.31","article-title":"Alpha-2 adrenergic receptor agonists: a review of current clinical applications","volume":"62","author":"Giovannitti","year":"2015","journal-title":"Anesth Prog"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib46","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1001\/jama.298.22.2644","article-title":"Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial","volume":"298","author":"Pandharipande","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00134-002-1579-9","article-title":"A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit","volume":"29","author":"Venn","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1378\/chest.11-2100","article-title":"Comparison and agreement between the Richmond Agitation-Sedation Scale and the Riker Sedation-Agitation Scale in evaluating patients' eligibility for delirium assessment in the ICU","volume":"142","author":"Khan","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.annemergmed.2025.12.004_bib49","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamainternmed.2023.7282","article-title":"Caring for hospitalized adults with opioid use disorder in the era of fentanyl: a review","volume":"184","author":"Englander","year":"2024","journal-title":"JAMA Intern Med"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064425014349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064425014349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:09:27Z","timestamp":1781298567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064425014349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0196064425014349"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2025.12.004","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of Medetomidine in the Illicit Drug Supply: Implications for Emergency Care and Withdrawal Management","name":"articletitle","label":"Article Title"},{"value":"Annals of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annemergmed.2025.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Emergency Physicians.","name":"copyright","label":"Copyright"}]}}